76 related articles for article (PubMed ID: 32267967)
1. Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2.
Parsons LN; Mullen EA; Geller JI; Chi YY; Khanna G; Glick RD; Aldrink JH; Vallance KL; Kim Y; Fernandez CV; Dome JS; Perlman EJ
Cancer; 2020 Jun; 126(12):2866-2871. PubMed ID: 32267967
[TBL] [Abstract][Full Text] [Related]
2. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group.
Ehrlich P; Chi YY; Chintagumpala MM; Hoffer FA; Perlman EJ; Kalapurakal JA; Warwick A; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Grundy PE; Fernandez CV; Ritchey ML; Dome JS
Ann Surg; 2017 Sep; 266(3):470-478. PubMed ID: 28795993
[TBL] [Abstract][Full Text] [Related]
3. The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group.
Hamilton TE; Ritchey ML; Haase GM; Argani P; Peterson SM; Anderson JR; Green DM; Shamberger RC
Ann Surg; 2011 May; 253(5):1004-10. PubMed ID: 21394016
[TBL] [Abstract][Full Text] [Related]
4. Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534.
Romao RLP; Aldrink JH; Renfro LA; Mullen EA; Murphy AJ; Brzezinski J; Malek MM; Benedetti DJ; Cost NG; Smith E; Dome JS; Davidoff AM; Treece A; Parsons LN; Fernandez CV; Tornwall B; Shamberger RC; Paulino A; Kalapurakal JA; Geller JI; Ehrlich PF
Pediatr Blood Cancer; 2024 Jul; 71(7):e30981. PubMed ID: 38637871
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2.
Benedetti DJ; Renfro LA; Tfirn I; Daw NC; Kalapurakal JA; Ehrlich PF; Khanna G; Perlman E; Warwick A; Gow KW; Paulino AC; Seibel NL; Grundy P; Fernandez CV; Geller JI; Mullen EA; Dome JS
Cancer; 2024 Jul; 130(13):2361-2371. PubMed ID: 38396300
[TBL] [Abstract][Full Text] [Related]
6. Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2.
Lovvorn HN; Renfro LA; Benedetti DJ; Kotagal M; Phelps HM; Ehrlich PF; Lo AC; Sandberg JK; Treece AL; Gow KW; Glick RD; Davidoff AM; Cost NG; Dix DB; Fernandez CV; Dome JS; Geller JI; Mullen EA
J Am Coll Surg; 2024 Apr; 238(4):733-749. PubMed ID: 38251681
[TBL] [Abstract][Full Text] [Related]
7. Current Realities of Wilms Tumor Burden and Therapy in Ghana.
Kontchou NT; Amankwah E; Seidu I; Stafman LL; Zhao S; Abrahams AOD; Appeadu-Mensah W; Lovvorn HN; Renner LA
J Pediatr Surg; 2024 Jul; 59(7):1342-1348. PubMed ID: 38589272
[TBL] [Abstract][Full Text] [Related]
8. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
[TBL] [Abstract][Full Text] [Related]
9. BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children's Oncology Group Study AREN03B2.
Goldstein JA; Renfro LA; Jennings LJ; Mullen EA; Geller J; Vallance K; Fernandez CV; Perlman EJ
Arch Pathol Lab Med; 2023 Dec; ():. PubMed ID: 38116848
[TBL] [Abstract][Full Text] [Related]
10. Update on Wilms tumor.
Aldrink JH; Heaton TE; Dasgupta R; Lautz TB; Malek MM; Abdessalam SF; Weil BR; Rhee DS; Baertschiger R; Ehrlich PF;
J Pediatr Surg; 2019 Mar; 54(3):390-397. PubMed ID: 30270120
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.
Evageliou N; Renfro LA; Geller J; Perlman E; Kalapurakal J; Paulino A; Dix D; Eklund MJ; Murphy AJ; Romao RLP; Ehrlich PF; Varela CR; Vallance K; Fernandez CV; Dome JS; Mullen EA
Cancer; 2024 Mar; 130(5):792-802. PubMed ID: 37902955
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016-2021: Successes and ongoing research priorities.
Holmes DM; Matatiyo A; Mpasa A; Huibers MHW; Manda G; Tomoka T; Mulenga M; Namazzi R; Mehta P; Zobeck M; Mzikamanda R; Chintagumpala M; Allen C; Nuchtern JG; Borgstein E; Aronson DC; Ozuah N; Nandi B; McAtee CL
Pediatr Blood Cancer; 2023 May; 70(5):e30242. PubMed ID: 36798020
[TBL] [Abstract][Full Text] [Related]
13. Considerations in the Diagnosis and Management of Pediatric Patients With Favorable Histology Wilms Tumor Who Present With Only Pulmonary Nodules.
Green DM
Pediatr Blood Cancer; 2016 Apr; 63(4):589-92. PubMed ID: 26626261
[TBL] [Abstract][Full Text] [Related]
14. Imaging of pediatric renal tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper focused on Wilms tumor and nephrogenic rests.
Artunduaga M; Eklund M; van der Beek JN; Hammer M; Littooij AS; Sandberg JK; Schenk JP; Servaes S; Singh S; Smith EA; Srinavasan A; Khanna G
Pediatr Blood Cancer; 2023 Jun; 70 Suppl 4(Suppl 4):e30004. PubMed ID: 36308415
[TBL] [Abstract][Full Text] [Related]
15. Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5.
Benedetti DJ; Varela CR; Renfro LA; Tornwall B; Dix DB; Ehrlich PF; Glick RD; Kalapurakal J; Perlman E; Gratias E; Seibel NL; Geller JI; Khanna G; Malogolowkin M; Grundy P; Fernandez CV; Dome JS; Mullen EA
Cancer; 2024 Mar; 130(6):947-961. PubMed ID: 37933882
[TBL] [Abstract][Full Text] [Related]
16. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.
Dome JS; Graf N; Geller JI; Fernandez CV; Mullen EA; Spreafico F; Van den Heuvel-Eibrink M; Pritchard-Jones K
J Clin Oncol; 2015 Sep; 33(27):2999-3007. PubMed ID: 26304882
[TBL] [Abstract][Full Text] [Related]
17. The impact of the route to diagnosis in nephroblastoma.
Mergen M; Welter N; Furtwängler R; Melchior P; Vokuhl C; Gessler M; Meier CM; Kager L; Schenk JP; Graf N
Cancer Med; 2024 May; 13(10):e7226. PubMed ID: 38785181
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group.
Metts J; Xue W; Gao Z; Ermoian R; Bradley JA; Arnold MA; Dasgupta R; Venkatramani R; Walterhouse D
Cancer; 2023 Jun; 129(11):1735-1743. PubMed ID: 36857314
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Barr EK; Naranjo A; Twist CJ; Tenney SC; Schmidt ML; London WB; Gastier-Foster J; Adkins ES; Mattei P; Handler MH; Matthay KK; Park JR; Maris JM; Desai AV; Cohn SL
Pediatr Blood Cancer; 2024 May; ():e31089. PubMed ID: 38822537
[TBL] [Abstract][Full Text] [Related]
20. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.
Ehrlich PF; Chi YY; Chintagumpala MM; Hoffer FA; Perlman EJ; Kalapurakal JA; Tornwall B; Warwick A; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Grundy PE; Fernandez CV; Dome JS
Cancer; 2020 Aug; 126(15):3516-3525. PubMed ID: 32459384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
